Bracco’s VueJect contrast system secures FDA and Health Canada approvals
August 12, 2026
The device will be sold initially in the US and Canada, with further submissions planned in additional markets.
The device will be sold initially in the US and Canada, with further submissions planned in additional markets.
Wandercraft, a Paris-based robotics company, announced that the FDA has granted clearance for Eve, its personal self-balancing exoskeleton designed to support upright mobility.